Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Else Nutrition Holdings Inc T.BABY

Alternate Symbol(s):  BABYF | T.BABY.WT.A

Else Nutrition Holdings Inc is an Israel-based company active in field of food manufacturing. The Company focuses on research, development, manufacturing, marketing and sale of innovative plant-based food and nutrition products and also maintain feeding accessories products to infants and dried food snacks.

TSX:BABY - Post Discussion

View:
Post by doggy123 on Dec 06, 2023 9:44pm

infant

Could someone specify when the infant formula pending will be approved by the FDA.............when it happen the stock will explode for sure...........in the news the other day they said infant milk 80% is going to China and companies can't keep up the demand with explosive price........man can't wait for this approval
Comment by ForesstGump on Dec 06, 2023 10:27pm
Saw in a youtubde video where the ceo said it could take total of 2 years with all the back and forth. That would definately be a game changer
Comment by doggy123 on Dec 07, 2023 8:03am
How long ago roughly you seen this video ForesstGump...thanks in advance 
Comment by m8magic on Dec 07, 2023 8:08am
link...??
Comment by majortom75 on Dec 07, 2023 9:09am
Not much additional info in their MD&A from last month but I also read somewhere recently that once they complete their clinical trial. it would be 18 to 24 months to approval. They've had difficulty sourcing a competing formula to act as a control in their study due to formula shortages in the US.
Comment by majortom75 on Dec 07, 2023 9:17am
Found it! "FDA approval pending on infant formula for U.S. expansion anticipated within 18 - 24 months from start day of the clinical study – currently in discussions with FDA on the study protocol and preclinical studies alignment" From their latest investor slide deck on their website. https://assets-global.website-files.com/63a1733b57a05c5d8230011c/64f9e2146523a6b54fab0d84_Else ...more  
Comment by m8magic on Dec 07, 2023 9:43am
Does FDA approve infant formulas before they can be marketed? No, FDA does not approve infant formulas before they can be marketed. However, all formulas marketed in the United States must meet federal nutrient requirements and infant formula manufacturers must notify the FDA prior to marketing a new formula.
Comment by m8magic on Dec 07, 2023 9:46am
o substantiate a new formulation, a manufacturer of an infant formula must conduct a growth monitoring study (GMS).  21 CFR Part 106.121 details the components of a GMS. ‍How long is the study? The study is 16 weeks long and infants must be no more than 11 days old at the time of enrollment. What information do we collect? Formula intake Anthropometric measurements  ...more  
Comment by m8magic on Dec 07, 2023 5:56pm
so clinical study time is only 16 weeks...and the requiement is only min of nutritional ingredients...FDA approval is NOT REQUIRED
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities